eschar: Definition, Uses, and Clinical Overview

Definition (What it is) of eschar

eschar is a dry or sometimes leathery layer of dead tissue on the skin surface.
It often looks black, brown, or dark gray and can form after injury or impaired blood supply.
Clinicians use the term in both reconstructive care (burns, wounds) and in evaluating complications after cosmetic surgery.
It is a clinical finding, not a treatment or a product.

Why eschar used (Purpose / benefits)

In medicine, the “purpose” of eschar is not that it is created intentionally in most modern settings, but that recognizing and describing it helps clinicians communicate what is happening in the skin and soft tissues. eschar signals that a portion of tissue has lost viability (blood flow and oxygen delivery) and has become necrotic (dead). That information matters because management differs from a simple scab, a superficial abrasion, or a normally healing incision.

From a patient and clinician perspective, identifying eschar can support several goals:

• Accurate diagnosis of wound depth and severity. eschar can indicate deeper injury than a typical scab, especially after burns, pressure injury, or compromised circulation.
• Treatment planning. Decisions about observation, debridement (removing nonviable tissue), dressings, topical agents, grafting, or flap coverage often depend on whether eschar is present and what type it is.
• Reconstructive planning and aesthetics. In plastic surgery, eschar may appear in areas with tension, swelling, or reduced perfusion (blood supply). Recognizing it early can influence scar management, contour outcomes, and whether secondary procedures are needed.
• Risk communication and documentation. The term helps teams track progression (stable vs expanding), which can be important for patient counseling and continuity of care.
• Infection and healing assessment. eschar may conceal the underlying wound bed, making it harder to judge moisture, granulation tissue, or signs that a wound is improving versus deteriorating.

Indications (When clinicians use it)

Clinicians commonly use the term eschar in situations such as:

• Thermal burns, where a firm “burn eschar” can form over deeper injury
• Pressure injuries (pressure ulcers), especially on heels or other bony prominences
• Ischemic wounds related to reduced circulation (varies by underlying cause)
• Traumatic skin injury with tissue death from crush, friction, or severe swelling
• Post-surgical skin compromise after cosmetic or reconstructive procedures (for example, around incision edges)
• Skin flap or graft compromise, where part of a reconstructed area loses viability
• Chemical injury to skin (including some medical/occupational exposures)

Contraindications / when it’s NOT ideal

Because eschar is a finding rather than a procedure, “contraindications” are best understood as situations where labeling something as eschar may be inaccurate, or where certain common approaches to eschar management may be less suitable.

Situations where another diagnosis or approach may be more appropriate include:

• Normal scabbing on a healing incision (a typical scab is not the same as eschar)
• Superficial epidermal peeling or crusting after resurfacing procedures (for example, some laser or chemical peel recovery changes), which may look dark but is not necrotic tissue
• Pigment change (post-inflammatory hyperpigmentation) without tissue death
• Adherent dressings, dried topical products, or dried blood mimicking a dark plaque
• Situations where aggressive removal is not appropriate, such as certain stable, dry lesions where clinicians may consider conservative management depending on location, perfusion, and patient factors (varies by clinician and case)
• Poor overall healing capacity, where the risks and benefits of debridement versus observation require careful individualized assessment (for example, significant vascular disease or complex systemic illness)

How eschar works (Technique / mechanism)

eschar does not “work” like a cosmetic technique (such as a filler, laser, or lift). It forms when tissue becomes nonviable and then dries or hardens on the surface.

At a high level:

• General approach: eschar is encountered in non-surgical and surgical settings. The “approach” refers to how clinicians manage it, not how it is created. Management may be conservative (observation and wound support) or procedural (debridement and reconstruction), depending on depth, location, and overall wound status.
• Primary mechanism: it represents necrosis—loss of tissue viability—followed by desiccation (drying) and adherence to the underlying tissues. In burns, the eschar can become stiff and inelastic.
• Typical tools/modalities used (for management): assessment tools (clinical exam and sometimes imaging or vascular studies), wound dressings, topical agents (varies by clinician and case), and debridement methods such as sharp/surgical debridement, mechanical techniques, enzymatic products (varies by material and manufacturer), and in selected contexts, operative excision with skin grafting or flap reconstruction.

In plastic and reconstructive practice, the clinical focus is often on preserving viable tissue, preventing progression, and planning closure that supports function (movement, sensation, protection) and appearance (scar quality, contour, symmetry).

eschar Procedure overview (How it’s performed)

There is no single “eschar procedure,” but there is a typical workflow clinicians follow when evaluating and managing eschar as part of wound or post-procedure care.

1. Consultation
   A clinician reviews symptoms, timing, prior procedures (if relevant), medications, and risk factors that can affect perfusion and healing.

2. Assessment / planning
   The area is examined for size, depth, adherence, moisture level (dry vs wet), borders, odor, drainage, surrounding redness, pain pattern, temperature, and whether there are signs of compromised blood flow. Planning may include deciding whether eschar is stable, whether the underlying tissue needs visualization, and whether reconstruction might be required.

3. Preparation / anesthesia
   If a procedure is needed (for example, debridement), anesthesia ranges from none to local anesthetic, procedural sedation, or general anesthesia depending on depth, location, and extent (varies by clinician and case).

4. Procedure
   Management can include cleansing, selecting dressings, offloading strategies for pressure-related areas, or debridement to remove nonviable tissue so the wound bed can be assessed. In burn or complex reconstructive cases, operative excision and coverage may be considered.

5. Closure / dressing
   The area may be left open under specific dressings, partially closed, or reconstructed with grafts/flaps when indicated. Dressings are selected to match wound goals (moisture balance, protection, monitoring access).

6. Recovery / follow-up
   Follow-up focuses on monitoring change in size and depth, edges, drainage, discomfort, and the condition of surrounding skin. Timelines vary by cause, location, depth, and patient factors.

Types / variations

eschar is described in several clinically meaningful ways. These “types” influence evaluation and management.

• Dry eschar
  Often firm, leathery, and adherent. It may appear black or dark brown. In some settings (such as certain heel lesions), clinicians may describe a “stable” dry eschar when it is intact and not showing signs of infection—management approaches vary by clinician and case.

• Moist (wet) eschar / slough-eschar mix
  May look softer, boggy, or partially separated with drainage. It can be associated with bacterial burden and can obscure the wound bed.

• Burn eschar
  Classically linked with deeper burns. It can restrict tissue expansion and, in circumferential limb or chest burns, may raise concerns about constriction (a specialized scenario managed in burn care).

• Pressure-injury eschar
  Commonly discussed on heels and sacral areas. It is often related to sustained pressure and reduced perfusion.

• Post-surgical eschar (incisional edge necrosis)
  Can occur when skin edges receive insufficient blood flow after closure under tension, swelling, hematoma/seroma pressure, or in the setting of compromised microcirculation. This can be relevant in breast surgery, body contouring, facelifts, and revisions (varies by anatomy, technique, and clinician).

• Ischemic/vascular-related eschar
  May occur when arterial inflow is limited or when microvascular circulation is impaired (the underlying cause matters for prognosis and management).

• Management variations: surgical vs non-surgical
  Some cases are managed conservatively with dressings and observation; others require procedural debridement, operative excision, and reconstruction.

• Anesthesia choices (when procedures are needed)
  Local anesthesia may be sufficient for small, superficial debridement; sedation or general anesthesia may be used for extensive or painful procedures (varies by clinician and case).

Pros and cons of eschar

Pros:

• Can act as a temporary protective cover over deeper tissue in certain contexts
• Provides a clear visual sign that tissue viability is compromised, prompting evaluation
• Helps clinicians classify wound severity and communicate consistently across teams
• Can support planning for reconstruction (graft, flap, staged closure) when needed
• In stable presentations, may allow time for demarcation (the boundary between viable and nonviable tissue becomes clearer), which can influence timing decisions (varies by clinician and case)

Cons:

• Indicates necrotic tissue, which can delay healing compared with viable tissue coverage
• May hide the true wound depth, making assessment more difficult without removal
• Can be associated with odor, drainage, or bacterial burden, especially when moist
• May lead to larger scars or contour changes after it separates or is removed
• In burns, can be rigid and constricting, complicating swelling and movement in some cases
• Can be distressing in appearance, particularly when it occurs after an elective cosmetic procedure

Aftercare & longevity

eschar does not have “longevity” like an implant or filler. Instead, clinicians consider how long it persists and what happens as it separates, is debrided, or is reconstructed. Duration varies widely based on cause (burn vs pressure vs post-surgical), size and depth, location, perfusion, infection status, and patient-specific healing factors.

General factors that can influence the course include:

• Underlying blood supply and tissue quality: areas with limited perfusion tend to heal more slowly and may have higher risk of breakdown.
• Degree of tension and swelling: in post-procedure settings, tension at closure and swelling can influence edge perfusion and how wounds evolve.
• Smoking/nicotine exposure: commonly discussed in plastic surgery because it can affect microcirculation and wound healing; risk magnitude varies by individual and exposure.
• Medical conditions and medications: diabetes, vascular disease, immune-modulating medications, and nutritional status can influence healing trajectories (varies by clinician and case).
• Sun exposure and pigmentation changes: after healing, color changes can persist and may fade slowly over time; outcomes vary by skin type and injury depth.
• Follow-up and wound monitoring: regular reassessment is often used to track progression and adjust the plan, particularly when the original cause is ongoing (pressure, friction, compromised circulation).
• Scar maturation: once the area has re-epithelialized or been reconstructed, scar remodeling may continue for many months, affecting texture and color.

Alternatives / comparisons

Because eschar is a clinical sign rather than a chosen cosmetic treatment, “alternatives” refer to alternative diagnoses (what else it might be) and alternative management strategies (how clinicians may address the underlying problem).

Common comparisons include:

• eschar vs scab (normal crust):
  A scab is typically dried blood/serum over a superficial injury with viable tissue underneath. eschar implies nonviable tissue and is more commonly associated with deeper injury or compromised perfusion.

• eschar vs slough:
  Slough is usually yellow/white, soft, and stringy nonviable tissue in a moist wound environment. eschar is typically darker and more leathery/dry, though mixed presentations occur.

• Conservative management vs debridement:
  Conservative strategies focus on protecting the area and supporting the wound environment while monitoring. Debridement removes nonviable tissue to better assess and manage the wound bed. The preferred approach varies by clinician and case, especially by location and vascular status.

• Topical/enzymatic approaches vs sharp/surgical approaches:
  Some clinicians use topical agents to help separate nonviable tissue (varies by material and manufacturer), while others use mechanical or surgical removal, particularly when faster visualization is needed.

• Secondary intention healing vs reconstruction (graft/flap):
  Some wounds heal by granulation and contraction over time. Others—especially larger, deeper, or functionally sensitive areas—may be reconstructed with skin grafts or flaps to restore durable coverage and contour (varies by anatomy and goals).

• Aesthetic camouflage vs revision procedures (after healing):
  After an eschar-related injury heals, appearance concerns may be addressed with scar-focused options (for example, silicone-based products, lasers, resurfacing, or surgical scar revision). Choice depends on scar type, skin tone, and timing, and varies by clinician and case.

Common questions (FAQ) of eschar

Q: Is eschar the same as a scab?
No. A scab usually forms over a superficial injury with living tissue underneath. eschar generally refers to dead (necrotic) tissue and often suggests deeper injury or impaired blood supply.

Q: What does eschar look like?
It is often black, dark brown, or gray and may look dry, thick, and leathery. Some eschar can appear softer or partially wet when mixed with other nonviable tissue.

Q: Does eschar mean there is an infection?
Not necessarily. eschar can form without infection, such as after a deep burn or ischemic injury. However, clinicians may evaluate for infection because necrotic tissue can complicate wound assessment and may coexist with bacterial overgrowth.

Q: Can eschar happen after cosmetic surgery?
It can, although it is not expected and is generally discussed as a complication related to reduced skin-edge blood flow. Examples include small areas along incision lines or in skin flaps, with risk influenced by anatomy, swelling, closure tension, and patient factors (varies by clinician and case).

Q: Is eschar painful?
Sensation varies. Some people report tenderness around the edges, while the central eschar may feel numb because the tissue is nonviable. Pain level depends on cause, depth, inflammation, and location.

Q: How is eschar treated or removed?
Management is individualized and may include observation with protective dressings, topical agents, or debridement (removal) using mechanical, enzymatic, or surgical methods. The approach depends on whether the eschar is dry vs moist, stable vs changing, and on the status of blood flow and surrounding tissue (varies by clinician and case).

Q: Will eschar leave a scar?
It can. Because eschar often reflects deeper injury, the healed area may have texture change, color change, or scarring. Final appearance depends on depth, location, skin type, reconstruction needs, and scar maturation over time.

Q: What kind of anesthesia is used if debridement is needed?
Small or superficial procedures may be done with local anesthesia, while larger or more sensitive areas may require sedation or general anesthesia. The choice depends on extent, patient comfort, and the clinical setting (varies by clinician and case).

Q: How much does eschar management cost?
Costs vary widely based on cause (burn care vs post-surgical wound care), setting (clinic vs operating room), number of visits, need for imaging, dressings, debridement, antibiotics, or reconstruction. Insurance coverage, if applicable, also varies by plan and indication.

Q: How long does it take for eschar to go away?
There is no single timeline. eschar may separate over time or be removed as part of treatment, and the underlying wound may take weeks to months to heal depending on depth and overall health factors. Recovery and outcomes vary by anatomy, technique, and clinician.